Abstract
A paradigm for assessing benzodiazepine receptor sensitivity was developed using intravenous midazolam in normal volunteers. After administration of incremental doses of midazolam, alterations in saccadic eye movement parameters and psychological self ratings were assessed. Significant changes included dose-dependent slowing of peak velocity, peak acceleration, peak deceleration, reduced saccade acceleration/deceleration ratio and saccade accuracy, and increased sedation self-ratings. Changes in saccade variables and sedation ratings were significantly correlated, and also correlated with plasma midazolam concentrations. No significant changes were seen in saccade latency or anxiety self-ratings. Pharmacological specificity of these changes was demonstrated by their reversal with the benzodiazepine antagonist flumazenil. This challenge paradigm appears to be a sensitive means of assessing benzodiazepine receptor function in man.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baloh RW, Sills AW, Kumley WR, Honrubia V (1975) The saccade velocity test. Neurology 25:1071–1076
Buchsbaum MS, Wu J, Haier R, Hazlett E, Ball R, Katz M, Sokolski K, Lagunas-Solar M, Langer D (1987) Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder. Life Sci 40:2393–2400
Dundee JW, Halliday NJ, Harper KW, Brogden RN (1984) Midazolam: a review of its pharmacological properties and therapeutic uses. Drugs 28:519–543
Fuchs AF, Kaneko CR (1981) A brain stem generator for saccadic eye movements. TINS 4:283–286
Glue P, White E, Wilson S, Ball D, Nutt D (1991) Pharmacology of saccadic eye movements in man (2): effects of the α 2-adrenoceptor ligands clonidine and idaxozan. Psychopharmacology 104
Glue P (1991) The pharmacology of saccadic eye movements. J Psychopharmacol (in press).
Griffiths AN, Marshall RW, Richens A (1984) Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance. Br J Clin Pharmacol 18:73s-82s
Haefely W, Hunkeler W (1988) The story of flumazenil. Eur J Anaesthesiol 2:3–14
Hindmarch I (1980) Psychomotor function and psychoactive drugs. Br J Clin Pharmacol 10:189–209
Hommer DW, Matsuo V, Wolkowitz O, Chrousos G, Greenblatt DJ, Weingartner H, Paul SM (1986) Benzodiazepine sensitivity in normal human subjects. Arch Gen Psychiatry 43:542–551
Hossmann V, Maling TJB, Hamilton CA, Reid JL, Dollery CT (1980) Sedative and cardiovascular effects of clonidine and nitrazepam. Clin Pharmacol Ther 28:167–176
Marshall RW, Griffiths AN, Richens A (1985) A microcomputer system to assess CNS depression from the analysis of the dynamics of saccadic eye movements. Br J Clin Pharmacol 20:304p–305p
Mercer AJ, Marshall RW, Richens A (1990) Saccadic eye movements as a method of psychometric assessment. In: Klepper ID, Saunders LD, Rosen M (eds) Ambulatory anaesthesia and sedation. Blackwell, Oxford, pp 88–105
Persson A, Ehrin E, Ericksson L, Farde L, Hedstrom OG, Litton JE, Mindus P, Sedvall G (1985) Imaging of C11 labeled Ro 15-1788 binding to benzodiazepine receptors in human brain by positron emission tomography. J Psychiatry Res 19:609–622
Reeves JG, Fragen RJ, Vinik HR, Greenblatt DJ (1985) Midazolam: pharmacology and uses. Anaesthesiology 62:310–324
Rothenberg S, Selkoe D (1981) Specific oculomotor deficit after diazepam. Psychopharmacology 74:232–236
Roy-Byrne PP, Lewis N, Villacres E, Diem H, Greenblatt DJ, Shader RI, Veith R (1989) Preliminary evidence of benzodiazepine subsensitivity in panic disorder. Biol Psychiatry 26:744–748
Roy-Byrne PP, Cowley DS, Greenblatt DJ, Shader RI, Hommer DW (1990) Reduced benzodiazepine sensitivity in panic disorder. Arch Gen Psychiatry 47:534–538
Shur E, Petursson H, Checkley S, Lader M (1983) Long-term benzodiazepine administration blunts growth hormone response to diazepam. Arch Gen Psychiatry 40:1105–1108
Wittenborn JR (1979) The effects of benzodiazepines on psychomotor performance. Br J Clin Pharmacol 7:61s-67s
Wurtz RH, Goldberg ME (eds) (1989) The neurobiology of saccadic eye movements. Elsevier, Amsterdam
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ball, D.M., Glue, P., Wilson, S. et al. Pharmacology of saccadic eye movements in man. Psychopharmacology 105, 361–367 (1991). https://doi.org/10.1007/BF02244431
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244431